Compounds of the formula (I) in which R, R1 and R3 have the meanings indicated in Claim 1, are inhibitors of pyruvate dehydrogenase kinase (PDHK), and can be employed, inter alia, for the treatment of diseases such as cancer.
公式(I)中的化合物,其中R、R1和R3的含义如权利要求1所述,是
丙酮酸脱氢酶激酶(PDHK)的
抑制剂,可以用于治疗诸如癌症等疾病。